Generation Bio(GBIO.US)

Last Updated 19:00:00 ET
longbridge loading

07:45 ETAdvaita Bio Launches iSCanGuide™: Unified Single-Cell and Spatial Transcriptomics Analysis, Powered by GPU-Accelerated Infrastructure

prnewswire·
US
AADI
0.00%
US
MBIO
+7.36%
US
IBBQ
+0.07%
prnewswire·
US
AADI
0.00%
US
MBIO
+7.36%
US
IBBQ
+0.07%

08:00 ETCGBIO Receives FDA 510(k) Clearance for Patient-Specific Titanium Implant 'EASYMADE TI'

prnewswire·
US
CGEN
-4.55%
US
GBIO
0.00%
US
CBIO
-0.38%
prnewswire·
US
CGEN
-4.55%
US
GBIO
0.00%
US
CBIO
-0.38%

Oncotelic Therapeutics 2025 10-K: Net income $249.02M; EPS $0.59

TradingView·
US
GTBP
+18.03%
US
GBIO
0.00%
US
ONCY
-3.14%
TradingView·
US
GTBP
+18.03%
US
GBIO
0.00%
US
ONCY
-3.14%

AllRock Bio begins patient dosing in Phase IIa ROCSTAR trial

WorldPharmaceuticals·
US
IBB
+0.10%
US
IHE
+1.26%
US
PBE
+0.11%
WorldPharmaceuticals·
US
IBB
+0.10%
US
IHE
+1.26%
US
PBE
+0.11%

20:00 ETCGBIO Showcases Comprehensive Medical Device Portfolio at KIMES 2026 Achieves KRW 5.3 Billion in Contract Results

prnewswire·
US
FBT
+0.54%
US
GBIO
0.00%
US
IBBQ
+0.07%
prnewswire·
US
FBT
+0.54%
US
GBIO
0.00%
US
IBBQ
+0.07%

Anthropic buys biotech startup Coefficient Bio in $400M deal: reports

TechCrunch·
US
XBI
-0.69%
US
IBB
+0.10%
US
GBIO
0.00%
TechCrunch·
US
XBI
-0.69%
US
IBB
+0.10%
US
GBIO
0.00%
© 2026 Longbridge｜Disclaimer